The recently developed FTO inhibitors, FB23 and FB23-2, proved to selectively suppress proliferation of and promoted AML cells apoptosis in vitro, leading to significant inhibition of human AML progression in xenotransplanted mice [218]. Here, FTO is linked to acute myeloid leukemia.